US Stock MarketDetailed Quotes
ALLO Allogene Therapeutics
Watchlist
2.520
+0.170+7.23% Close 12/01 16:00 ET
2.460-0.060-2.38%
Pre 04:05 ET
2.550High2.230Low2.37MVolume
2.340Open2.350Pre Close5.80MTurnover2.09%Turnover RatioLossP/E (TTM)424.06MMarket Cap8.44052wk HighLossP/E (Static)168.28MShares2.23052wk Low0.73P/B285.75MFloat Cap55.000Historical High--Dividend TTM113.39MShs Float2.230Historical Low--Div YieldTTM13.62%Amplitude2.448Avg Price1Lot Size
Allogene Therapeutics Key Stats
Quarterly+Annual
YOY

(Q3)2023/09/30 | (Q2)2023/06/30 | (Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | (Q3)2022/09/30 | (Q2)2022/06/30 | (Q1)2022/03/31 | (FY)2021/12/31 | (Q4)2021/12/31 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | -15.70%465.51M | 0.30%491.96M | 4.94%471.22M | 13.12%517.32M | 13.12%517.32M | 14.22%552.23M | -16.54%490.49M | -35.81%449.05M | -44.76%457.3M | -44.76%457.3M |
-Cash and cash equivalents | -6.87%69.25M | 61.14%154.76M | 30.07%109.93M | -64.28%61.9M | -64.28%61.9M | -60.87%74.36M | -57.03%96.04M | -64.32%84.51M | -5.47%173.31M | -5.47%173.31M |
-Short-term investments | -17.08%396.26M | -14.51%337.2M | -0.89%361.29M | 60.36%455.42M | 60.36%455.42M | 62.84%477.87M | 8.30%394.45M | -21.22%364.54M | -55.94%283.99M | -55.94%283.99M |
Prepaid assets | ---- | ---- | ---- | ---- | ---- | -13.12%16.83M | 55.81%22.54M | 25.57%20.69M | ---- | ---- |
Other current assets | --7.95M | --10.14M | --10.24M | -17.95%11.5M | -17.95%11.5M | ---- | ---- | ---- | --14.02M | --14.02M |
Total current assets | -16.80%473.45M | -2.13%502.1M | 2.50%481.47M | 12.20%528.82M | 12.20%528.82M | 13.17%569.06M | -14.80%513.03M | -34.40%469.74M | -44.23%471.32M | -44.23%471.32M |
Non current assets | ||||||||||
Net PPE | -9.12%181.47M | -8.50%186.7M | 8.21%191.81M | 8.51%196.43M | 8.51%196.43M | 21.28%199.69M | 23.72%204.05M | 8.52%177.26M | 13.04%181.02M | 13.04%181.02M |
-Gross PPE | -2.22%229.08M | -1.72%230.74M | 13.65%232.21M | 14.16%233.32M | 14.16%233.32M | 27.49%234.28M | 29.20%234.78M | 14.68%204.31M | 18.11%204.38M | 18.11%204.38M |
-Accumulated depreciation | -37.64%-47.61M | -43.31%-44.04M | -49.31%-40.39M | -57.89%-36.89M | -57.89%-36.89M | -80.91%-34.59M | -83.01%-30.73M | -82.48%-27.05M | -80.98%-23.36M | -80.98%-23.36M |
Investments and advances | -62.14%37.54M | -70.43%62.5M | -81.93%53.91M | -80.56%71.97M | -80.56%71.97M | -74.97%99.15M | -38.63%211.33M | 5.06%298.3M | 78.02%370.18M | 78.02%370.18M |
Other non current assets | 1.01%19.87M | 2.31%19.67M | 1.79%19.68M | 23.28%19.86M | 23.28%19.86M | 26.02%19.67M | 25.87%19.23M | 22.96%19.33M | 10.19%16.11M | 10.19%16.11M |
Total non current assets | -25.00%238.87M | -38.14%268.87M | -46.37%265.41M | -49.19%288.26M | -49.19%288.26M | -44.74%318.51M | -17.15%434.62M | 6.89%494.89M | 48.24%567.31M | 48.24%567.31M |
Total assets | -19.74%712.33M | -18.64%770.97M | -22.57%746.87M | -21.33%817.08M | -21.33%817.08M | -17.76%887.57M | -15.89%947.64M | -18.19%964.63M | -15.41%1.04B | -15.41%1.04B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -43.82%6.21M | 5.31%10.23M | 68.67%14.69M | 35.45%13.89M | 35.45%13.89M | -3.95%11.05M | -11.74%9.71M | -41.46%8.71M | -1.30%10.26M | -1.30%10.26M |
-accounts payable | -43.82%6.21M | 5.31%10.23M | 68.67%14.69M | 35.45%13.89M | 35.45%13.89M | -3.95%11.05M | -11.74%9.71M | -41.46%8.71M | -1.30%10.26M | -1.30%10.26M |
Current accrued expenses | -15.55%31.2M | 28.82%44.26M | 38.44%38.44M | -13.01%15.81M | -13.01%15.81M | -11.26%36.94M | -0.95%34.36M | -30.13%27.76M | -37.33%18.17M | -37.33%18.17M |
Current debt and capital lease obligation | ---- | ---- | --6.19M | 87.56%6M | 87.56%6M | ---- | ---- | ---- | --3.2M | --3.2M |
-Current capital lease obligation | ---- | ---- | --6.19M | 87.56%6M | 87.56%6M | ---- | ---- | ---- | --3.2M | --3.2M |
Current deferred liabilities | -73.45%236K | -72.61%229K | -32.76%273K | 109.22%885K | 109.22%885K | 143.56%889K | 174.10%836K | 69.87%406K | -98.92%423K | -98.92%423K |
Current liabilities | -22.99%37.64M | 21.85%54.72M | 61.58%59.59M | 13.17%54.52M | 13.17%54.52M | -8.63%48.87M | -2.37%44.91M | -32.77%36.88M | -48.92%48.17M | -48.92%48.17M |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | -6.83%90.1M | -6.53%91.82M | 35.46%93.51M | 36.03%95.12M | 36.03%95.12M | 90.97%96.71M | 91.83%98.23M | 33.72%69.04M | 37.63%69.93M | 37.63%69.93M |
-Long term capital lease obligation | -6.83%90.1M | -6.53%91.82M | 35.46%93.51M | 36.03%95.12M | 36.03%95.12M | 90.97%96.71M | 91.83%98.23M | 33.72%69.04M | 37.63%69.93M | 37.63%69.93M |
Other non current liabilities | -26.91%1.49M | -40.37%1.52M | -56.73%1.51M | -61.96%1.57M | -61.96%1.57M | -60.71%2.03M | -55.23%2.55M | 25.04%3.49M | 33.80%4.13M | 33.80%4.13M |
Total non current liabilities | -7.24%91.59M | -7.38%93.34M | 31.02%95.02M | 30.57%96.69M | 30.57%96.69M | 76.91%98.74M | 77.08%100.79M | 33.28%72.53M | 37.41%74.05M | 37.41%74.05M |
Total liabilities | -12.46%129.22M | 1.63%148.07M | 41.32%154.61M | 23.71%151.21M | 23.71%151.21M | 35.05%147.61M | 41.57%145.7M | 0.13%109.4M | -17.53%122.23M | -17.53%122.23M |
Shareholders'equity | ||||||||||
Share capital | 16.67%168K | 15.97%167K | 2.10%146K | 1.41%144K | 1.41%144K | 1.41%144K | 1.41%144K | 1.42%143K | 1.43%142K | 1.43%142K |
-common stock | 16.67%168K | 15.97%167K | 2.10%146K | 1.41%144K | 1.41%144K | 1.41%144K | 1.41%144K | 1.42%143K | 1.43%142K | 1.43%142K |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | -29.17%-1.47B | -33.52%-1.41B | -35.75%-1.33B | -36.82%-1.24B | -36.82%-1.24B | -37.74%-1.14B | -41.01%-1.06B | -44.72%-983.2M | -39.76%-903.35M | -39.76%-903.35M |
Paid-in capital | 8.73%2.06B | 8.98%2.04B | 4.61%1.93B | 4.91%1.91B | 4.91%1.91B | 5.29%1.89B | 5.46%1.87B | 5.63%1.85B | 5.60%1.82B | 5.60%1.82B |
Gains losses not affecting retained earnings | 81.39%-2.41M | 66.43%-3.85M | 35.84%-5.93M | -286.68%-9.93M | -286.68%-9.93M | -3,155.78%-12.96M | -3,334.73%-11.47M | -9,057.43%-9.25M | -1,057.84%-2.57M | -1,057.84%-2.57M |
Total stockholders'equity | -21.20%583.1M | -22.33%622.91M | -30.75%592.26M | -27.34%665.87M | -27.34%665.87M | -23.71%739.96M | -21.67%801.95M | -20.06%855.23M | -15.12%916.41M | -15.12%916.41M |
Total equity | -21.20%583.1M | -22.33%622.91M | -30.75%592.26M | -27.34%665.87M | -27.34%665.87M | -23.71%739.96M | -21.67%801.95M | -20.06%855.23M | -15.12%916.41M | -15.12%916.41M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--